Avalyn Pharma (AVLN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Avalyn Pharma (AVLN) is Moderate Underperform.

The composite score behind that read is -0.30, weighing +0.56 of bullish evidence against -0.33 bearish.

Avalyn Pharma last closed at $27.03, -3.91% on the session.

Against the IVW growth benchmark the position is -4.83% over the forecast window.

The read is built from 13 underlying insights — 2 bullish and 11 bearish.

Agreement across those insights is 85%.

16 graded predictions for AVLN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Avalyn Pharma is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.25B.

StockMap tracks Avalyn Pharma as the 49th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Avalyn Pharma ranks 74th of 128 in the group, against a group median of -0.24.